Esperion Therapeutics, Inc. (NASDAQ: ESPR), an emerging pharmaceutical company focused on developing and commercializing first-in-class, oral low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies for the treatment of hypercholesterolemia and other cardiometabolic risk markers, today announced that president and chief executive officer, Tim M. Mayleben, will present at the Stifel 2014 Healthcare Conference in New York City, N.Y. on Wednesday, November 19, 2014 at 11:30 a.m. Eastern Time.
Help employers find you! Check out all the jobs and post your resume.
